Financial reports
NT 10-K
Notice of late annual filing
29 Sep 16
10-Q
2016 Q3
Quarterly report
9 May 16
10-Q
2016 Q2
Quarterly report
12 Feb 16
10-Q
2016 Q1
Quarterly report
12 Nov 15
10-K
2015 FY
Annual report
14 Oct 15
NT 10-K
Notice of late annual filing
25 Sep 15
10-Q
2015 Q3
Quarterly report
12 May 15
10-Q
2015 Q2
Quarterly report
12 Feb 15
10-Q
2015 Q1
Quarterly report
14 Nov 14
10-K
2014 FY
Annual report
14 Oct 14
Current reports
8-K
Termination of a Material Definitive Agreement
24 Apr 17
8-K
Entry into a Material Definitive Agreement
28 Apr 16
8-K
Entry into a Material Definitive Agreement
8 Dec 15
8-K
Intellect Neurosciences, Inc. Engages Troy Rohn, PhD as Lead Scientific Advisor for TauC3 Antibody Program
26 Oct 15
8-K
Intellect Neurosciences, Inc. Issues Letter to Shareholders
21 Oct 15
8-K
Entry into a Material Definitive Agreement
6 Jul 15
8-K
Entry into a Material Definitive Agreement
6 Jan 15
8-K
Amendments to Articles of Incorporation or Bylaws
19 Dec 14
8-K
Intellect Neurosciences, Inc. Issues Letter to Shareholders
29 Sep 14
8-K
Amendments to Articles of Incorporation or Bylaws
15 Aug 14
Registration and prospectus
8-A12G
Registration of securities
18 Aug 14
D
$2.32M in equity / debt / options, sold $2.32M, 7 investors
7 May 10
D
$800K in debt / options / securities to be acquired, sold $450K, 1 investor
10 Sep 09
REGDEX
Notice of sale of securities
8 Feb 07
SB-2/A
Registration of securities for small business issuer (amended)
27 Jun 06
REGDEX
Notice of sale of securities
26 Apr 06
REGDEX
Notice of sale of securities
26 Apr 06
SB-2/A
Registration of securities for small business issuer (amended)
10 Apr 06
SB-2/A
Registration of securities for small business issuer (amended)
9 Feb 06
SB-2/A
Registration of securities for small business issuer (amended)
8 Feb 06
Other
REVOKED
Registration or securities revoked
30 Nov 18
CT ORDER
Confidential treatment order
20 Dec 11
CT ORDER
Confidential treatment order
26 Oct 09
UPLOAD
Letter from SEC
28 Jul 09
CORRESP
Correspondence with SEC
6 Jul 09
CORRESP
Correspondence with SEC
22 May 09
CT ORDER
Confidential treatment order
6 Apr 09
CORRESP
Correspondence with SEC
27 Mar 09
UPLOAD
Letter from SEC
17 Mar 09
UPLOAD
Letter from SEC
5 Mar 09
Ownership
SC 13G/A
Intellect Neurosciences, Inc.
14 Feb 18
SC 13G/A
Intellect Neurosciences, Inc.
14 Feb 17
SC 13G/A
Intellect Neurosciences, Inc.
16 Feb 16
SC 13G
Intellect Neurosciences, Inc.
5 Feb 16
SC 13G
Intellect Neurosciences, Inc.
10 Mar 15
SC 13G
Beneficial ownership report
10 Feb 15
SC 13G
Beneficial ownership report
23 Sep 14